This inventor holds 4 USPTO granted patents. Top assignee: Bristol-Myers Squibb Pharma Company. Active years: 2004-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kennett Square, PA (US) (2004 - 2005)
- Kennett Sq., PA (US) (2006)
Company Filing History:
Years Active: 2004-2006
Title: The Innovations of Donald Joseph Philip Pinto
Introduction
Donald Joseph Philip Pinto is a notable inventor based in Kennett Square, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that act as inhibitors of trypsin-like serine proteases.
Latest Patents
Pinto holds a total of 4 patents. His latest patents include the 6-5, 6-6, or 6-7 heterobicycles as factor Xa inhibitors. These patents describe heterobicycles of Formula I or pharmaceutically acceptable salt forms, wherein ring P is a 6-membered heteroaromatic and ring M is a 5-, 6-, or 7-membered non-aromatic carbocycle or heterocycle. The compounds are particularly useful as inhibitors of factor Xa. Additionally, he has patents for 5-6 to 5-7 heterobicycles as factor Xa inhibitors, which describe similar structures with different ring configurations.
Career Highlights
Pinto is currently employed at Bristol-Myers Squibb Pharma Company, where he continues to innovate in the pharmaceutical sector. His work focuses on developing new therapeutic agents that can effectively target specific proteases.
Collaborations
Throughout his career, Pinto has collaborated with esteemed colleagues such as Renhua Li and Robert Anthony Galemmo, Jr. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Donald Joseph Philip Pinto's work in the field of pharmaceuticals showcases his dedication to innovation and the development of important therapeutic agents. His contributions are significant in the ongoing fight against diseases that involve serine proteases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
